Expert Ratings
Easily search Stocks, Mutual Funds, Articles and Videos
Dr Lal Pathlabs is a diagnostic services company with a dominant presence in North India which accounts for around 65% of the company’s revenue. Dr Lal Pathlabs operates its own testing labs, while collection centres are run on a franchise model. The company got listed on NSE and BSE in December 2015. The National Reference Lab of the company is located at New Delhi. The portfolio of products of the company includes pathology, radiology and cardiology tests across both preventive and wellness categories. The customers of the company are individual patients and hospitals.
Track the companies of Group.
| Sales Growth | Profit Growth | Expense Growth | Stock Price CAGR |
|---|---|---|---|
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Dr. Lal Pathlabs was incorporated as ‘Dr. Lal PathLabs Private Limited’, a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana (RoC) on February 14, 1995 at Delhi. Subsequently, the name of the company was changed to ‘Dr. Lal PathLabs Limited’ upon conversion of the company into a public limited company pursuant to a special resolution of the shareholders of the company dated August 7, 2015 and a fresh certificate of incorporation was issued by the RoC on August 19, 2015. The company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations.
The company is well known and widely regarded for consistently introducing pioneer tests and technologies in Indian Diagnostics Market. The company has launched multiple “Center of Excellence” in recent times focusing on various specialities such as Genevolve (Genetic Testing), L-ACE(Autoimmunity), L-CoRD (Reproductive Diagnosis) & L-CID (Infectious Diseases) defining the steps towards Medical Excellence. The company has expanded its test offering which include basic preventive health packages “SwasthFit” to most advanced investigations such as Comprehensive Genomic Profile, Myeloid testing for Haematological Malignancies & Amyloid Typing Solutions. The company is actively working to introduce the Artificial Intelligence based algorithm in multiple diagnostics areas such as Histopath & Haematology to improve the efficiency, accuracy and reproducibility of results.
Business area of the company
The company is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
Popular tests of the company
Awards and accreditations
Major events and milestones
Comment